463 related articles for article (PubMed ID: 16143696)
21. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
22. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
[TBL] [Abstract][Full Text] [Related]
23. [Risk reduction of acute heart failure with initial administration of beta-blockers].
Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
[No Abstract] [Full Text] [Related]
24. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
25. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
Lechat P
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
[TBL] [Abstract][Full Text] [Related]
26. Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
Dobre D; van Veldhuisen DJ; Goulder MA; Krum H; Willenheimer R
Cardiovasc Drugs Ther; 2008 Oct; 22(5):399-405. PubMed ID: 18528751
[TBL] [Abstract][Full Text] [Related]
27. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
Krum H; Haas SJ; Eichhorn E; Ghali J; Gilbert E; Lechat P; Packer M; Roecker E; Verkenne P; Wedel H; Wikstrand J
Eur Heart J; 2005 Oct; 26(20):2154-8. PubMed ID: 16014644
[TBL] [Abstract][Full Text] [Related]
28. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
Tarasov NI; Kokov AN; Barbarash LS
Ter Arkh; 2006; 78(9):38-43. PubMed ID: 17076223
[TBL] [Abstract][Full Text] [Related]
29. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
30. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
Atkins CE; Keene BW; Brown WA; Coats JR; Crawford MA; DeFrancesco TC; Edwards NJ; Fox PR; Lehmkuhl LB; Luethy MW; Meurs KM; Petrie JP; Pipers FS; Rosenthal SL; Sidley JA; Straus JH
J Am Vet Med Assoc; 2007 Oct; 231(7):1061-9. PubMed ID: 17916031
[TBL] [Abstract][Full Text] [Related]
31. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
[TBL] [Abstract][Full Text] [Related]
32. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
Haas SJ; Vos T; Gilbert RE; Krum H
Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
[TBL] [Abstract][Full Text] [Related]
33. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet; 1999 Jan; 353(9146):9-13. PubMed ID: 10023943
[TBL] [Abstract][Full Text] [Related]
34. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
[No Abstract] [Full Text] [Related]
35. Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
Alsheikh-Ali AA; Wang PJ; Rand W; Konstam MA; Homoud MK; Link MS; Estes NA; Salem DN; Al-Ahmad AM
Am Heart J; 2004 Jun; 147(6):1061-5. PubMed ID: 15199356
[TBL] [Abstract][Full Text] [Related]
36. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction.
Ishani A; Weinhandl E; Zhao Z; Gilbertson DT; Collins AJ; Yusuf S; Herzog CA
J Am Coll Cardiol; 2005 Feb; 45(3):391-9. PubMed ID: 15680718
[TBL] [Abstract][Full Text] [Related]
38. Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?
Remme WJ
Cardiol Clin; 2007 Nov; 25(4):581-94; vii. PubMed ID: 18063162
[TBL] [Abstract][Full Text] [Related]
39. [Outpatient medical and nurse management program in patients with chronic heart failure in a large territorial area in Piedmont. Four years of follow-up].
Conte MR; Mainardi L; Iazzolino E; Casetta M; Asteggiano R; Lai F; Lusardi R; Sasso L
Ital Heart J Suppl; 2005 Dec; 6(12):812-20. PubMed ID: 16444925
[TBL] [Abstract][Full Text] [Related]
40. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
